Principles: Extending the utility of [35S]GTPγS binding assays

Trends in Pharmacological Sciences

Volumn 24, Issue 2, 2003, Pages 87-90

  Milligan, Graeme ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HYBRID PROTEIN; SULFUR 35;

HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; REVIEW;

ANIMALS; BINDING SITES; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; RADIOLIGAND ASSAY; SULFUR RADIOISOTOPES;

EID: 0037305047     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(02)00027-5     Document Type: Review

References (25)

1. Moore K., Rees S. Cell-based versus isolated target screening: how lucky do you feel? J. Biomol. Screen. 6:2001;69-74.
2. 35S]GTPγS binding. Methods Enzymol. 344:2002;3-14.
3. Seta K., et al. AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. J. Biol. Chem. 277:2002;9268-9277.
4. Hill S.J., et al. Reporter-gene systems for the study of G-protein-coupled receptors. Curr. Opin. Pharmacol. 1:2002;526-532.
5. 12 families of heterotrimeric G proteins. J. Biol. Chem. 274:1999;27351-27358.
6. q/11 in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 134:2001;257-264.
7. Willets J.M., et al. Endogenous G protein-coupled receptor kinase 6 regulates M3 muscarinic acetylcholine receptor phosphorylation and desensitization in human SH-SY5Y neuroblastoma cells. J. Biol. Chem. 277:2002;15523-15529.
8. Gilchrist A., et al. Design and use of C-terminal minigene vectors for studying role of heterotrimeric G proteins. Methods Enzymol. 344:2002;58-69.
9. s signaling: Targeting the receptor-G protein interface using a peptide minigene encoding the Gαs carboxyl terminus. J. Biol. Chem. 277:2002;28631-28640.
10. 35S]guanosine-5′-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay. J. Pharmacol. Exp. Ther. 289:1999;946-955.
11. Porter A.C., et al. M1 muscarinic receptor signaling in mouse hippocampus and cortex. Brain Res. 944:2002;82-99.
12. 2C receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking. Mol. Pharmacol. 62:2002;578-589.
13. i3 activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signalling. Mol. Pharmacol. 62:2002;590-601.
14. Sim-Selley L.J., Childers S.R. Neuroanatomical localization of receptor-activated G proteins in brain. Methods Enzymol. 344:2002;42-58.
15. Schoneberg T. The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. Rev. Physiol. Biochem. Pharmacol. 144:2002;143-227.
16. i/o activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype. Br. J. Pharmacol. 132:2001;950-958.
17. 11. J. Pharmacol. Exp. Ther. 302:2002;1080-1088.
18. Milligan G. Construction and analysis of function of GPCR-G protein fusion proteins. Meth. Enzymol. 343:2002;260-273.
19. Wurch T., Pauwels P.J. Analytical pharmacology of G protein-coupled receptors by stoichiometric expression of the receptor and Gα protein subunits. J. Pharmacol. Toxicol. Methods. 45:2001;3-16.
20. sα fusion protein. Eur. J. Biochem. 260:1999;661-666.
21. 11α is not required for interaction with β/γ complex. J. Biol. Chem. 276:1999;35883-35890.
22. 11α requires both β/γ interactions and an aromatic group 4 amino acid from the C-terminus of the G protein. J. Biol. Chem. 277:2002;25707-25714.
23. 1-adrenoceptor. Mol. Pharmacol. 62:2002;747-755.
24. Fong C.W., Milligan G. Analysis of agonist function at fusion proteins between the IP prostanoid receptor and cognate, unnatural and chimaeric G proteins. Biochem. J. 342:1999;457-463.
25. q-proteins. Mol. Pharmacol. 58:2000;954-966.